marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 07.11.2024
PMV Pharmaceuticals Bilanz 2011-2024 | PMVP
Bilanz Jährlich PMV Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-24.4 M | -94.3 M | -161 M | - | -73.3 M | -30.3 M | - | - | - | - | - | - | - |
Langfristige Schulden |
12.4 M | 13.4 M | 10.8 M | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
852 K | 528 K | 403 K | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | 169 M | 107 M | - | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
14 M | 10.8 M | 12.2 M | 6.41 M | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
26.5 M | 24.3 M | 23 M | 6.41 M | 174 M | 110 M | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-310 M | -241 M | -168 M | -110 M | -75.4 M | -50.1 M | - | - | - | - | - | - | - |
Vermögenswerte |
252 M | 270 M | 332 M | 366 M | 103 M | 63.5 M | - | - | - | - | - | - | - |
Zahlungsmittel |
37.7 M | 108 M | 172 M | 361 M | - | - | - | - | - | - | - | - | - |
Buchwert |
226 M | 246 M | 309 M | 359 M | -70.5 M | -46.1 M | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
226 M | 246 M | 309 M | 359 M | -70.5 M | -46.1 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich PMV Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
12 M | 11.8 M | 12.4 M | 12.7 M | 13 M | 13.2 M | 13.4 M | 12.1 M | 12.2 M | 11.5 M | 10.8 M | 10.7 M | 10.6 M | 302 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
25.6 M | 23.2 M | 26.5 M | 23.4 M | 24.4 M | 23.8 M | 24.3 M | 23.8 M | 23.6 M | 23.2 M | 23 M | 19.2 M | 18.1 M | 6.1 M | 6.41 M | 6.41 M | 6.41 M | 6.41 M | 4.57 M | 4.57 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-346 M | -326 M | -310 M | -294 M | -278 M | -260 M | -241 M | -222 M | -203 M | -186 M | -168 M | -149 M | -134 M | -121 M | -110 M | -110 M | -110 M | -110 M | -75.4 M | -75.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
223 M | 238 M | 252 M | 261 M | 242 M | 254 M | 270 M | 285 M | 301 M | 315 M | 332 M | 344 M | 356 M | 354 M | 366 M | 366 M | 366 M | 366 M | 103 M | 103 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
48.8 M | 48.5 M | 37.7 M | 52.1 M | 68.2 M | 143 M | 108 M | 99.8 M | 87.1 M | 116 M | 172 M | 177 M | 189 M | 209 M | 361 M | 361 M | 361 M | 361 M | 73.3 M | 73.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
198 M | 214 M | 226 M | 238 M | 218 M | 230 M | 246 M | 261 M | 277 M | 292 M | 309 M | 325 M | 338 M | 348 M | 359 M | 359 M | 359 M | 359 M | 98.5 M | 98.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
198 M | 214 M | 226 M | 238 M | 218 M | 230 M | 246 M | 261 M | 277 M | 292 M | 309 M | 325 M | 338 M | 348 M | 359 M | 359 M | 359 M | 359 M | -70.5 M | -70.5 M | -57.7 M | -51.9 M | -46.1 M | - | - | - | -29.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung